内镜甲状腺癌根治术争议与评价  

Controversies in Endoscopic Thyroidectomyfor Differentiated Thyroid Cancer

作　　者：仇明[1] 

机构地区：[1]第二军医大学长征医院微创外科,上海200003

出　　处：《中国实用外科杂志》2010年第3期197-199,共3页Chinese Journal of Practical Surgery

摘　　要：目前临床上关于内镜甲状腺癌根治术争议的焦点是原发肿瘤和颈淋巴结的安全切除范围。虽然缺乏相关的临床长期随访资料的支持,但现有的临床对照研究和短期随访结果已初步证明,将内镜甲状腺癌根治术应用于部分选择性病例的外科治疗,在技术上是安全、可行的。鉴于各种径路内镜甲状腺手术操作特点的差异,经胸乳径路内镜手术的适应证仅限于甲状腺乳头状微小癌,而经胸骨上窝小切口内镜辅助甲状腺手术的应用范围已拓展到部分低危乳头状癌病人。Currently the debate on endoscopic thyroidectomy for differentiated thyroid cancer is focused on the range of safety resection of primary tumor and cervical lymph nodes. Although lacking the support from related long-term clinical follow-ups, the current clinical comparison studies and short-term data have somewhat proved that applying endoscopic thyroidectomy to some selected cases of thyroid cancer is technically safe and feasible. Considering the operational differences among endoscopic surgeries through various approaches, the BAET is only applicable to papillary thyroid microcarcinoma, while has been expanded to some the feasible range of MIVAT low-risk papillary carcinoma patients.

关 键 词：内镜 甲状腺切除术 甲状腺癌 

分 类 号：R6[医药卫生—外科学]